Evidence for anti-leukocyte antibodies as a mechanism for drug-induced agranulocytosis.
D000082:Acetaminophen / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000276:immunology; D000818:Animals; D001803:Blood Transfusion; D002245:Carbon Dioxide / Q000378:metabolism; D002250:Carbon Radioisotopes; D005258:Felty Syndrome / Q000276:immunology; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D007518:Isoantibodies; D007962:Leukocytes / Q000276:immunology* / Q000378:metabolism; D008750:Methyldopa / Q000009:adverse effects; D011137:Polystyrenes; D011241:Prednisone / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D011441:Propylthiouracil / Q000009:adverse effects; D011817:Rabbits / Q000276:immunology
D002250:Carbon Radioisotopes; D007074:Immunoglobulin G; D007518:Isoantibodies; D011137:Polystyrenes; D011324:Primidone; D002245:Carbon Dioxide; D000082:Acetaminophen; D008750:Methyldopa; D011441:Propylthiouracil; D005947:Glucose; D011241:Prednisone